secwatch / observer
8-K filed May 22, 2026, 5:05 PM ET ticker TPST CIK 0001544227
leadership confidence high sentiment negative materiality 0.40

Three directors resign from Tempest Therapeutics board effective May 22, 2026

Tempest Therapeutics, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christine Pellizzari

Director
TPST · Tempest Therapeutics, Inc.
Effective
2026-05-22
Filed
May 22, 2026, 5:05 PM ET
On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
Departed

Michael Raab

Director
TPST · Tempest Therapeutics, Inc.
Effective
2026-05-22
Filed
May 22, 2026, 5:05 PM ET
On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
Departed

Stephen Brady

Director
TPST · Tempest Therapeutics, Inc.
Effective
2026-05-22
Filed
May 22, 2026, 5:05 PM ET
On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christine Pellizzari resigned as Director at Tempest Therapeutics, Inc..

Action
resigned
Role
Director
Exact text from the filing
On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Raab resigned as Director at Tempest Therapeutics, Inc..

Action
resigned
Role
Director
Exact text from the filing
On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Brady resigned as Director at Tempest Therapeutics, Inc..

Action
resigned
Role
Director
Exact text from the filing
On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.
View on SEC.gov

Tempest Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-237150
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.